The Freshfields Podcast
By Freshfields
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Freshfields
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 18
Reviews: 0
Episodes: 110
Description
We are a global law firm with a long-standing track record of successfully supporting the world’s leading national and multinational corporations, financial institutions and governments on ground-breaking and business-critical mandates.
| Episode | Date |
|---|---|
|
Essential Antitrust #49: Clarity in Antitrust: inside the 10 key themes shaping 2026
|
Jan 21, 2026 |
|
Essential Antitrust #48: Antitrust meets AI: How regulators approach AI-driven pricing and predictive analytics
|
Jan 07, 2026 |
|
Well-Caffeinated: What’s Past is Prologue — Assessing the Changed Legal Landscape from Year 1 of the Second Trump Administration and Looking Ahead at What Year 2 May Bring
|
Dec 17, 2025 |
|
No Worse Off #20: 2025 in Review
|
Dec 17, 2025 |
|
No Worse Off #19: Restructuring “à la francaise”
|
Dec 10, 2025 |
|
Tax Matters: Autumn Budget 2025 – a stealthy smorgasbord?
|
Nov 27, 2025 |
|
No Worse Off #18: Innovative Capital Solutions Tools in the Italian Market
|
Nov 03, 2025 |
|
Human-Centered Innovation – A conversation with Stephanie Toney, CBO at Diatiro Health
|
Oct 13, 2025 |
|
Well-Caffeinated: Private Capital Goes Retail: the Global Push to Democratize Access to Private Capital Investments
|
Sep 24, 2025 |
|
No Worse Off #17: Distressed disposals and LMEs – Hunkemöller and Selecta
|
Sep 03, 2025 |
|
The Arbitration Act 2025 is now in force. What are the key things you need to know?
|
Aug 07, 2025 |
|
No Worse Off #16: Petrofac in the Court of Appeal
|
Jul 22, 2025 |
|
Reward(ing) Half Hour - Episode 5 Navigating Employment Claims: Share Plans, Bonuses and Beyond
|
Jul 10, 2025 |
|
No Worse Off #15: UK restructuring plan turns five
|
Jul 03, 2025 |
|
Eureka: Fresh Takes on Capital Markets with Freshfields Episode #4: Midseason Proxy Review
|
Jun 18, 2025 |
|
Eureka: Fresh Takes on Capital Markets from Freshfields Episode #3: What to expect from SEC Enforcement
|
Jun 09, 2025 |
|
Tax matters: Trump 2.0 - the intersection of US tax and trade policy
|
Jun 05, 2025 |
|
Looking Forward: How AI is Transforming Healthcare and MedTech
|
May 21, 2025 |
|
Essential Antitrust #47: Chat with EC’s Daniele Calisti: More room for procompetitive efficiencies?
|
May 20, 2025 |
|
'EUnpacked' Episode #4: The EU’s first Omnibus - simplification or deregulation?
|
May 19, 2025 |
|
No Worse Off #14: Managing consumer redress liabilities: recent restructuring experience and the motor finance sector
|
May 14, 2025 |
|
Securing the Digital Future #4: A Conversation with Athina Tsitsou and June Lowry
|
May 06, 2025 |
|
Eureka: Fresh Takes on Capital Markets with Freshfields Episode #2: IPOs and other Routes to Capital and Liquidity: “The Garden of Forking Paths”
|
May 05, 2025 |
|
Eureka: Fresh Takes on Capital Markets from Freshfields: Episode #1: Disclosure and Governance During a Trade War
|
Apr 22, 2025 |
|
Ethan Klingsberg Explores the Global Secondaries Trend with Ivet Bell
|
Apr 10, 2025 |
|
Essential Antitrust #46: UK’s DMCCA consumer protection reforms: Key changes and how to prepare
|
Apr 07, 2025 |
|
No Worse Off #13: Spotlight on the Middle East
|
Apr 03, 2025 |
|
Well-Caffeinated: Playing the Long Game: A Conversation with Val Jacob
|
Mar 31, 2025 |
|
Securing the Digital Future #3: Balancing Act: Regulatory Approaches to Privacy in Content Moderation
|
Mar 11, 2025 |
|
No Worse Off #12: Meet Paul, Mark and Nick: our new London private credit and capital solutions trio
|
Mar 05, 2025 |
|
Managing Risk in Asia #10: Powering the change in Asia’s energy transition
|
Feb 27, 2025 |
|
Securing the Digital Future #2: Navigating the UK’s Approach to Online Safety
|
Feb 18, 2025 |
|
MedTech - Innovation & Inclusion: How Nada Hanafi advocates for diversity in MedTech
|
Feb 12, 2025 |
|
No Worse Off #11: International sanctions
|
Feb 03, 2025 |
|
Essential Antitrust #45: Antitrust agency leadership: stepping onto a new stage
|
Jan 24, 2025 |
|
Essential Antitrust #44: Redefining the role of antitrust in 2025: our Ten Key Themes forecast
|
Jan 21, 2025 |
|
Securing the Digital Future #1: Insights on online safety in the US
|
Jan 08, 2025 |
|
Life Sciences x Technology – A conversation with Derek Underwood
|
Dec 19, 2024 |
|
No Worse Off #10: 12 Headlines from 2024
|
Dec 17, 2024 |
|
Reward(ing) Half Hour: Episode 4 Applying Malus and Clawback in practice
|
Dec 12, 2024 |
|
Essential Antitrust #43: EU welcomes Teresa Ribera as new Competition Commissioner: business impact
|
Dec 11, 2024 |
|
Well-Caffeinated: What’s Brewing for the 2025 Funds Regulatory Environment?
|
Dec 04, 2024 |
|
No Worse Off #9: Managing Litigation Risk in Restructurings
|
Nov 28, 2024 |
|
Tax Matters: Autumn Budget 2024 – Delivering difficult decisions
|
Oct 31, 2024 |
|
Essential Antitrust #42: HSR rules changes: how to successfully navigate the new US merger control filing
|
Oct 30, 2024 |
|
No Worse Off #8: LMEs in England
|
Oct 28, 2024 |
|
Episode #3: EU elections - What you need to know about the von der Leyen II Commission
|
Oct 24, 2024 |
|
Out of the shadows: The growing regulatory spotlight on private capital
|
Oct 21, 2024 |
|
No Worse Off #7: Women in Restructuring
|
Sep 05, 2024 |
|
No Worse Off #6: Liability management
|
Aug 06, 2024 |
|
Essential Antitrust #41: Vertical restraints enforcement: trends to watch
|
Jul 23, 2024 |
|
Navigating Cybersecurity Risks in the Healthcare Sector
|
Jul 12, 2024 |
|
Episode #2: EU elections - A business outlook
|
Jul 04, 2024 |
|
No Worse Off #5: Cross-border restructurings
|
Jun 27, 2024 |
|
Essential Antitrust #40: America’s impending outbound investment controls: what investors need to know
|
Jun 27, 2024 |
|
Managing Risk in Asia #9: Southeast Asia – time to shine?
|
Jun 07, 2024 |
|
Reward(ing) Half Hour: Episode 3 Next Stop: CSOP
|
Jun 05, 2024 |
|
Reward(ing) Half Hour: Episode 2 Remuneration vs Compensation – the Transatlantic Pay Debate
|
May 08, 2024 |
|
No Worse Off #4: Richard Tett, 30 years in restructuring
|
May 02, 2024 |
|
Essential Antitrust #39: UK in-depth merger reviews: new process adopted by the CMA
|
Apr 29, 2024 |
|
No Worse Off #3: UK Restructuring Plans – Relevant Alternative, timetabling and jurisdiction
|
Apr 15, 2024 |
|
No Worse Off #2: After the battles, a coming of age for the UK restructuring plan?
|
Apr 04, 2024 |
|
Reward(ing) Half Hour: Being prepared for the (not so) unexpected: planning for executive exits
|
Mar 25, 2024 |
|
Tax Matters: Spring Budget 2024 – The Hunt for Blue October
|
Mar 07, 2024 |
|
No Worse Off #1: Overview of current restructuring trends
|
Mar 05, 2024 |
|
Essential Antitrust #38: What businesses can expect from China’s revised merger control regime
|
Feb 08, 2024 |
|
Impressions from the J.P. Morgan Healthcare Conference – A MedTech Perspective
|
Feb 01, 2024 |
|
Essential Antitrust #37: Antitrust in 2024: competition enforcement takes center stage
|
Jan 18, 2024 |
|
Legends of Tech #1: Turing with Vint and Whit: Boris Feldman in conversation with Vinton G. Cerf and Whitfield Diffie
|
Jan 12, 2024 |
|
Essential Antitrust Asia #9: updates with ABNR on antitrust in Indonesia
|
Jan 10, 2024 |
|
Managing Risk in Asia #8: Opportunities for Asian and US investors post-US Executive Order on outbound investments
|
Dec 28, 2023 |
|
Tax Matters: Trends in tax disputes – what should businesses be aware of?
|
Dec 13, 2023 |
|
Essential Antitrust #36: The UK’s Digital Markets, Competition and Consumers Bill – what you need to know
|
Dec 08, 2023 |
|
Essential Antitrust #35: Gender Inclusive Antitrust Toolkit: a new lens for policy and enforcement
|
Nov 29, 2023 |
|
Tax Matters: Autumn Statement 2023 – tax cuts in the NIC of time?
|
Nov 23, 2023 |
|
How secondaries have become primary to GPs and LPs
|
Nov 17, 2023 |
|
From chaos to control: making the case for legal project managers
|
Nov 16, 2023 |
|
Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends
|
Oct 18, 2023 |
|
Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges
|
Sep 18, 2023 |
|
MedTech Across Borders – Recent Developments in Japan and the US
|
Sep 06, 2023 |
|
MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more
|
Aug 01, 2023 |
|
Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways
|
Jul 26, 2023 |
|
Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia
|
Jul 24, 2023 |
|
Essential Antitrust #31: Recent developments in antitrust, data and IP – generative AI and MedTech
|
Jul 20, 2023 |
|
Essential Antitrust #30: ASSA ABLOY/Spectrum Brands: a breakthrough for M&A remedies in the US?
|
Jun 08, 2023 |
|
Essential Antitrust #29: Microsoft/Activision: parallel reviews in high-innovation digital deals
|
May 25, 2023 |
|
Global Perspectives on Health Data Offerings and Considerations for Innovators
|
May 04, 2023 |
|
Essential Antitrust #28: Collusion or collaboration: competition and the fight for net zero
|
Apr 18, 2023 |
|
Essential Antitrust #27: Some Key Takeaways from the Enforcers Roundtable at the 2023 ABA Antitrust Spring Meeting
|
Apr 04, 2023 |
|
MedTech Diversity and Inclusion – A Conversation with Jhaymee Tynan
|
Mar 28, 2023 |
|
Episode #1: The EU’s Corporate Sustainability Due Diligence Directive– a turning point for business
|
Mar 22, 2023 |
|
Essential Antitrust Asia #8: Hot topics in China antitrust
|
Mar 17, 2023 |
|
Tax Matters: Ready, Steady, Growth – Business tax implications of the UK Spring Budget 2023
|
Mar 16, 2023 |
|
Essential Antitrust #26: Foreign subsidy control: EU gears up to review deals and business conduct
|
Feb 20, 2023 |
|
Essential Antitrust #25: Antitrust in 2023: 10 key themes - growing unpredictability and brand new enforcement tools
|
Jan 25, 2023 |
|
MedTech - A Conversation with Stacy Hostetler
|
Dec 15, 2022 |
|
Essential Antitrust #24: Cartel enforcement is back: dawn raids in Europe and new targets in the US
|
Dec 12, 2022 |
|
MedTech - A Conversation with Gloria Seibert
|
Dec 01, 2022 |
|
Tax Matters podcast: How will the UK Autumn Statement 2022 affect your business?
|
Nov 18, 2022 |
|
Essential Antitrust #23: Merger challenges in US courts: deciphering US antitrust agencies’ recent string of defeats
|
Oct 26, 2022 |
|
Great (stakeholder) expectations: Episode 4 - Activists all around
|
Oct 20, 2022 |
|
Great (stakeholder) expectations: Episode 3 - A bastion of support for social issues
|
Oct 18, 2022 |
|
Great (stakeholder) expectations: Episode 2 - Unpacking the status of climate disclosures
|
Oct 13, 2022 |
|
State of play on Pillar Two
|
Oct 12, 2022 |
|
Great (stakeholder) expectations: Episode 1 - A turning point for ESG
|
Oct 11, 2022 |
|
Essential Antitrust Asia #7: Key antitrust issues in Japan
|
Sep 22, 2022 |
|
Managing Risk in Asia #6: Managing transactional risks in life science investments in Asia
|
Aug 23, 2022 |
|
Tax matters: what is the impact of the proposed restrictions to the UK sovereign immunity tax exemption?
|
Aug 10, 2022 |
|
A new European AML authority – A year on
|
Jul 20, 2022 |
|
MedTech and Health Equity for Women - A Conversation with Marissa Fayer
|
Jun 28, 2022 |